Skip to main content

Teva Pharmaceutical Industries Ltd. (TEVA)

NYSE: TEVA · IEX Real-Time Price · USD
8.46 0.04 (0.48%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap9.33B
Revenue (ttm)16.23B
Net Income (ttm)726.00M
Shares Out1.10B
EPS (ttm)0.66
PE Ratio12.82
Forward PE3.02
Dividendn/a
Ex-Dividend Daten/a
Volume8,340,121
Open8.38
Previous Close8.42
Day's Range8.34 - 8.50
52-Week Range7.94 - 13.30
Beta1.31
AnalystsHold
Price Target11.39 (+34.6%)
Earnings DateOct 27, 2021

About TEVA

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central...

IndustryPharmaceuticals
Founded1901
CEOKaare Schultz
Employees37,100
Stock ExchangeNYSE
Ticker SymbolTEVA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 18 analysts, the average rating for TEVA stock is "Hold." The 12-month stock price forecast is 11.39, which is an increase of 34.63% from the latest price.

Price Target
$11.39
(34.63% upside)
Analyst Consensus: Hold

News

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts

These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months. The post 7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts appeared f...

1 day ago - InvestorPlace

2 Popular Healthcare Stocks I'd Avoid at All Costs

There's an entire galaxy full of better places to invest your money.

Other symbols:BLUE
5 days ago - The Motley Fool

5 Warren Buffett Stocks Are Screaming Buys in December

Riding the Oracle of Omaha's coattails is often a moneymaking proposition.

Other symbols:AMZNBACBMYV
5 days ago - The Motley Fool

Teva Announces Launch of an Authorized Generic of Epiduo® Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), i...

TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of an authorized generic of ...

1 week ago - Business Wire

3 Top Stocks That'll Make You Richer in December (and Beyond)

Bargains abound for growth and value investors.

Other symbols:PLNHFSE
1 week ago - The Motley Fool

Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of E...

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the early tender results in connection with its previously announced tender offers (...

4 weeks ago - Business Wire

'You cannot critique us for trying to help,' says Teva CEO on sustainability-linked bond launch

Kare Schultz, CEO of Teva Pharmaceuticals, discusses the launch of an sustainability-linked bond which has raised $5 billion dollars committed to increasing access to medicine in lower- and middle-incom...

1 month ago - CNBC International TV

4 No-Brainer Buffett Stocks to Buy With $500 in November

Riding the Oracle of Omaha's coattails has been a moneymaking move for decades.

Other symbols:BMYMAV
1 month ago - The Motley Fool

Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Me...

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced ambitious commitments to address two of today's greatest global crises—access to medicines and clim...

1 month ago - Business Wire

Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sust...

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully upsized and priced approximately $5,000,000,000 (equivalent) of...

1 month ago - Business Wire

Why Teva Pharmaceutical Stock Is Jumping Today

The company won in a California opioid-related lawsuit.

1 month ago - The Motley Fool

California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements About Opioids

PARSIPPANY, N.J.--(BUSINESS WIRE)--Today, Orange County, California, Superior Court Judge Peter Wilson issued a decision finding that Teva did not cause a public nuisance in Orange County, Los Angeles C...

1 month ago - Business Wire

California judge rules for drugmakers in major opioid lawsuit

A California judge on Monday said he would rule against several large counties who accused four drugmakers of fueling an opioid epidemic, saying they had failed at trial to prove their $50 billion case.

Other symbols:ABBVENDPJNJ
1 month ago - Reuters

Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial

Teva Pharmaceuticals Industries Ltd (NYSE: TEVA) announced results from the Phase 3 trial comparing TV-46000/mdc-IRM once monthly (q1m) and TV-46000/mdc-IRM once every two months (q2m) with placebo for ...

1 month ago - Benzinga

Teva's (TEVA) Q3 Earnings and Revenues Miss, Stock Down

Teva Pharmaceutical Industries' (TEVA) shares decline after the company misses both earnings and sales estimates for third-quarter 2021. Meanwhile, it reaffirms its 2021 guidance.

1 month ago - Zacks Investment Research

Why Teva Pharmaceutical Industries Fell Today

The pharmaceutical giant whiffs on both the top and bottom lines in its Q3.

1 month ago - The Motley Fool

We see a stable U.S. market place for our generics, says Teva Pharma CEO

Meg Tirrell joins 'The Exchange' with Teva Pharmaceuticals CEO Kåre Schultz on the company's most recent earnings report and its guidance for the future.

1 month ago - CNBC Television

Teva Q3 Earnings Fall Short Of Expectations; Reaffirms FY21 Guidance

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q3 sales reached $3.89 billion, shrinking 2% Y/Y or 3% in local currency terms, missing the consensus of $4.03 billion. The decrease was mainly due to l...

1 month ago - Benzinga

Teva Pharm Q3 profit misses estimates on lower North American sales

Israel-based Teva Pharmaceutical Industries reported third-quarter profit that missed estimates, citing lower North American sales while Huntington's disease treatment Austedo and migraine product Ajovy...

1 month ago - Reuters

Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today its intention to issue $4,000,000,000 of sustainability-linked senior notes. The not...

1 month ago - Business Wire

Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it has commenced tender offers (the “Offers”) to purchase for cash for a combin...

1 month ago - Business Wire

Teva Reports Third Quarter 2021 Financial Results

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended September 30, 2021. Mr. Kåre Schultz, Teva's President and CEO, ...

1 month ago - Business Wire

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

TEL AVIV & WENDELSHEIM, Germany--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and MODAG GmbH today announced a strategic collaboration on the exclusive worldwide licensing ...

1 month ago - Business Wire

Teva Has Turned the Corner

Shareholders of Teva Pharmaceutical Industries ( TEVA , Financial) thave now taken a multi-year beating. Since the company hit an all-time high in 2015 and bit off more than it can chew, over-paying for...

1 month ago - GuruFocus

Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced 25 presentations examining new ...

1 month ago - Business Wire